Alphatec (US:ATEC)2025-06-16 16:42Financial Performance & Growth - ATEC experienced a sector-leading revenue Compound Annual Growth Rate (CAGR) of approximately 40% over 5 years, driven by market share expansion[4] - Total revenue for 2023 reached $482 million, representing a 37% year-over-year increase[7] - Surgical revenue in 2023 was $423 million, a 39% increase year-over-year[7] - EOS revenue for 2023 amounted to $59 million, reflecting a 24% year-over-year growth[7] - The company projects 2024 revenue to be $595 million, indicating a 24% growth[8] Market Position & Strategy - ATEC is focused on an $8 billion spine market[4] - The company's strategy involves meeting unmet needs in spine surgery through clinical distinction[19] - ATEC is a 100% spine-focused company, differentiating it from larger, less focused competitors[17, 20] - ATEC aims to achieve cash flow break-even in 2025, supporting self-funded future growth[4] Innovation & Technology - ATEC is integrating unprecedented information into spine care with enabling technology[19] - The company is advancing deformity treatment with procedural sophistication[19] - ATEC is developing the EOS Catalyst, expected in mid-2024, to automate alignment reports and surgical planning[72, 73]